Some COVID-19 Infections Can Progress To Critical Quickly; Scientists Work To Develop Diagnostics, Vaccines

Bloomberg: There Is a ‘Tipping Point’ Before Coronavirus Kills (Gale, 3/8).

Devex: U.K. government to fund coronavirus rapid diagnostic test (Worley, 3/6).

New York Times: How Deadly Is Coronavirus? What We Know and What We Don’t (Bui et al., 3/7).

Reuters: $2 billion needed to develop COVID-19 shot, says epidemic response group (Kelland, 3/6).

STAT: To develop a coronavirus vaccine, synthetic biologists try to outdo nature (Begley, 3/9).

USA TODAY: Children aren’t at great risk for coronavirus, WHO report says, but some doctors aren’t so sure (Rodriguez, 3/6).

VOA: China: Coronavirus Vaccine Could Be Ready for ‘Emergency Use’ in April (Xie, 3/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.